representation of Eastern European and of Third World nations; in fact 46% of the papers were from the USA. The papers deal with the advancing front of knowledge of acute renal failure; 56% deal with animal experimental models, 38% deal with problems of clinical medicine, and the remainder combine both approaches.
There are many excellent accounts of the pathophysiology of the syndrome. It is now well recognized that the causation is multifactorial, including cortical vasoconstriction, tubular leakage and obstruction, and an abrupt fall of the glomerular filtration rate due to preglomerular vasospasm, capillary endothelial swelling, alteration in the glomerula ultrafiltration coefficient, increase of intrarenal renin, and intraglomerular coagulation. Interesting descriptions are given of the efficacy of preventative measures in cases of acute circulatory failure, including better postoperative care, adequate rehydration, osmotic diuresis and dopamine injections. These advances are focussing interest in cases due to nephrotoxins, especially the aminoglycosides, radiological contrast media, and heavy metals including the antineoplastic agent, cis-diaminedichlorplatinum. This is a highly specialized monograph which will serve as a useful reference text for medical libraries, and experts in the treatment of cases of renal failure. The editor, Dr H E Eliahou, is to be congratulated in making this material available to a larger audience than those experts who were privileged to attend this satellite symposium.
M 0 MILNE

Emeritus Professor of Medicine Westminster Medical School. London
Psychological Problems Before and After Myocardial Infarction (Advances in Cardiology, vol 29) H Denolin (ed) pp 155 Basel: S Karger 1982 The cardiological trails of the last two decades are petering out. Cardiologists who know their subject well and wish to avoid coronary illness are not sure where to turn. Risk factor modification has not improved the chances of survival (Multiple Risk Factor Intervention Trial), and drug prophylaxis has been disappointing, Betablockade has its advocates but the Betablocker Heart Attack Trial (Journal of the American Medical Association (1981) 246, 2073-4) suggests that prevention depends upon the dosage being well above the range that disqualifies pilots from flying, and the public may not accept the offer of suffering 30 man-years of side-effects to save one middle-aged life. Most coronary deaths are too quick for prevention by coronary care units in hospitals, and there is a growing recogrution of the failure of bypass operations to recover lost health and working ability in many cases.
The idea is gaining ground.that coronary heart disease has much to do with the way individuals fit their society. In certain circumstances some are driven to adopt catabolic and self-destructive metabolic processes which cause. them to be extruded. If this idea is right, prevention must come to depend upon our ability to recognize the vulnerable and to teach them how to modify their responses.
The arguments for this idea and the weaknesses of the case are presented here by a score of leaders in the field. The book is a delight. Small, wellbound and printed, simply written, a pleasure to hold and read, its contents and references provide an excellent guide to an aspect of cardiology which has been neglected, not because it is unimportant, but because its measurement is difficult.
P G F NIXON
Consultant Cardiologist Charing Cross Hospital. London
The Modem Management of Congestive Heart Failure. John Hamer pp 168 £8.50 London: Lloyd-Luke 1982 This excellent and very readable monograph constitutes a balanced review of the numerous methods now available to treat congestive heart failure -by which the failure of both the right and left ventricles is implied.
The use of diuretics is critically assessed and attention is drawn to dangers which have only recently been appreciated. The pharmacology and clinical applications of digitalis are fully discussed. In fact, the two chapters devoted to that drug comprise the largest section of the book, but this allocation of space is fully justified in view of the current clash of views concerning both the dangers and possible benefits of digitalis. The author shows convincingly that estimation of plasma levels by radioimmunoassay cannot reasonably be expected to separate the therapeutic from toxic effects. The current evidence for and against the use of inotropic drugs includes discussion of the recent specific B-1 receptor agonists, the phosphodiesterase inhibitors, the ionophores and amrinone. As would be expected, the value of 'unloading' vasodilator drugs, including angiotensin blockers, is considered. There is no evidence that they improve the underlying disease or, for that matter, significantly affect the prognosis; even so, the adverse rebound reactions on their abrupt withdrawal does suggest some long-term benefit. The final chapter is a most useful guide to the often very difficult problem of dealing rationally with heart failure resulting from cardiac infarction.
